Sidley Austin LLP has advised Bio-Techne Corporation. Sullivan & Cromwell LLP and Freshfieds have advised Merck KGaA, Darmstadt, Germany. Linklaters has advised BNP Paribas, Deutsche Bank...
Merck KGaA to Acquire Bio-Techne Corporation for US$11.3 Billion
B-Flexion Sells Boston Pharmaceuticals’ Lead Liver Disease Asset to GSK for Up to $2 Billion
Sullivan & Cromwell has advised B-Flexion. Boston Pharmaceuticals, owned by B-Flexion, has reached an agreement to sell its lead asset, efimosfermin alfa, to GSK for up...
Merck’s $3.9 Billion Acquisition of SpringWorks Therapeutics
Sullivan & Cromwell advised Merck KGaA, Darmstadt, Germany, while Goodwin Procter advised SpringWorks Therapeutics on the transaction. Skadden advised Centerview Partners and Goldman Sachs & Co....
Abiomed’s $18 Billion Merger Agreement with Johnson & Johnson
Sullivan & Cromwell advised Abiomed on the deal, while Cravath represented Johnson & Johnson. Davis Polk advised J.P. Morgan Securities LLC as financial adviser to Johnson...
Samsung Venture Investment Corporation’s Investment in ConsenSys
Sullivan & Cromwell advised ConsenSys on the deal. ConsenSys Software, an industry-leading blockchain software company, completed an investment by Samsung Venture Investment Corporation valuing ConsenSys at...